NeoGenomics launches private offering of USD 275 million convertible senior notes due 2032

NeoGenomics, Inc.

NeoGenomics, Inc.

NEO

0.00

  • NeoGenomics launched a private offering of USD 275 million convertible senior notes due 2032, with an option for initial purchasers to buy USD 41.25 million more.
  • Total potential issuance size: USD 316.25 million.
  • Proceeds earmarked for capped call transactions, repurchases of its 0.25% convertible senior notes due 2028, up to USD 25 million in share repurchases, general corporate purposes.
  • Notes expected to be senior unsecured, with semi-annual interest, convertible into cash, shares, or a mix at NeoGenomics’ election.
  • Issuer redemption permitted from July 6, 2029 if the stock trades at least 130% of the conversion price for a specified period.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606151724BIZWIRE_USPR_____20260615_BW452524) on June 15, 2026, and is solely responsible for the information contained therein.